Functional Relevance of a Novel SlyX Motif in Non-conventional Secretion of Insulin-degrading Enzyme

被引:23
作者
Glebov, Konstantin [1 ]
Schuetze, Sebastian [1 ]
Walter, Jochen [1 ]
机构
[1] Univ Bonn, Dept Neurol, D-53127 Bonn, Germany
关键词
UNCONVENTIONAL PROTEIN SECRETION; AMYLOID BETA-PROTEIN; SUBSTRATE RECOGNITION; LOCALIZATION; BRAIN; DEGRADATION; REMOVES; PATHWAY; DISEASE; DOMAIN;
D O I
10.1074/jbc.C110.217893
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Insulin-degrading enzyme (IDE) is a Zn2+ metalloprotease with a characteristic inverted catalytic motif. IDE is ubiquitously expressed and degrades peptide substrates including insulin, endorphin, and the amyloid-beta peptide. Although IDE is mainly expressed in the cytosol, it can also be found on the cell surface and in secreted form in extracellular fluids. As IDE lacks a characteristic signal sequence that targets the protein to the classical secretory pathway, release of the enzyme involves non-conventional mechanisms. However, functional domains of IDE involved in its secretion remain elusive. By bioinformatical, biochemical, and cell biological methods, we identified a novel amino acid motif ((EKPPHY858)-E-853) close to the C terminus of IDE and characterized its function in the non-conventional secretion of the protein. Because of its close homology to an amino acid sequence found in bacterial proteins belonging to the SlyX family, we propose to call it the SlyX motif. Mutagenesis revealed that deletion of this motif strongly decreased the release of IDE, whereas deletion of a potential microbody-targeting signal at the extreme C terminus had little effect on secretion. The combined data indicate that the non-conventional secretion of IDE is regulated by the newly identified SlyX motif.
引用
收藏
页码:22711 / 22715
页数:5
相关论文
共 24 条
[1]   CELLULAR-LOCALIZATION OF INSULIN-DEGRADING ENZYME IN RAT-LIVER USING MONOCLONAL-ANTIBODIES SPECIFIC FOR THIS ENZYME [J].
AKIYAMA, H ;
SHII, K ;
YOKONO, K ;
YONEZAWA, K ;
SATO, S ;
WATANABE, K ;
BABA, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 155 (02) :914-922
[2]  
Behl Mamta, 2009, Cerebrospinal Fluid Res, V6, P11, DOI 10.1186/1743-8454-6-11
[3]   Insulin-degrading enzyme in the Alzheimer's disease brain:: prominent localization in neurons and senile plaques [J].
Bernstein, HG ;
Ansorge, S ;
Riederer, P ;
Reiser, M ;
Frölich, L ;
Bogerts, B .
NEUROSCIENCE LETTERS, 1999, 263 (2-3) :161-164
[4]   The periplasmic Escherichia coli peptidylprolyl cis,trans-isomerase FkpA -: I.: Increased functional expression of antibody fragments with and without cis-prolines [J].
Bothmann, H ;
Plückthun, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (22) :17100-17105
[5]   Insulin-Degrading Enzyme Sorting in Exosomes: A Secretory Pathway for a Key Brain Amyloid-β Degrading Protease [J].
Bulloj, Ayelen ;
Leal, Maria C. ;
Xu, Huaxi ;
Castano, Eduardo M. ;
Morelli, Laura .
JOURNAL OF ALZHEIMERS DISEASE, 2010, 19 (01) :79-95
[6]   Insulin-degrading enzyme does not require peroxisomal localization for insulin degradation [J].
Chesneau, V ;
Perlman, RK ;
Li, WL ;
Keller, GA ;
Rosner, MR .
ENDOCRINOLOGY, 1997, 138 (08) :3444-3451
[7]   The choroid plexus removes β-amyloid from brain cerebrospinal fluid [J].
Crossgrove, JS ;
Li, GJ ;
Zheng, W .
EXPERIMENTAL BIOLOGY AND MEDICINE, 2005, 230 (10) :771-776
[8]   Insulin-degrading enzyme rapidly removes the β-amyloid precursor protein intracellular domain (AICD) [J].
Edbauer, D ;
Willem, M ;
Lammich, S ;
Steiner, H ;
Haass, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (16) :13389-13393
[9]   Alternative splicing of human insulin-degrading enzyme yields a novel isoform with a decreased ability to degrade insulin and amyloid β-protein [J].
Farris, W ;
Leissring, MA ;
Hemming, ML ;
Chang, AY ;
Selkoe, DJ .
BIOCHEMISTRY, 2005, 44 (17) :6513-6525
[10]   Insulin-Degrading Enzyme: Structure-Function Relationship and its Possible Roles in Health and Disease [J].
Fernandez-Gamba, A. ;
Leal, M. C. ;
Morelli, L. ;
Castano, E. M. .
CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (31) :3644-3655